Edition:
United States

Sorrento Therapeutics Inc (SRNE.OQ)

SRNE.OQ on NASDAQ Stock Exchange Capital Market

2.45USD
14 Dec 2017
Change (% chg)

-- (--)
Prev Close
$2.45
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
163,695
52-wk High
$6.05
52-wk Low
$1.50

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.06 December 16 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 1 1 1 1
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.50 1.50 1.50 1.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 1 19.96 19.96 19.96 --
Quarter Ending Mar-18 1 3.60 3.60 3.60 --
Year Ending Dec-17 1 151.41 151.41 151.41 8.53
Year Ending Dec-18 1 23.22 23.22 23.22 3.90
Earnings (per share)
Quarter Ending Dec-17 1 -0.06 -0.06 -0.06 --
Quarter Ending Mar-18 1 -0.29 -0.29 -0.29 --
Year Ending Dec-17 1 -0.11 -0.11 -0.11 -0.35
Year Ending Dec-18 1 -1.06 -1.06 -1.06 0.19
LT Growth Rate (%) 1 37.00 37.00 37.00 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 4.25 121.91 117.66 2,768.47
Quarter Ending Jun-17 4.34 4.66 0.33 7.51
Quarter Ending Mar-17 4.02 4.87 0.86 21.27
Quarter Ending Dec-16 2.99 4.02 1.03 34.37
Quarter Ending Sep-16 2.04 2.24 0.21 10.11

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 19.96 12.03 4.30 4.30 --
Quarter Ending Mar-18 3.60 4.65 18.30 18.30 --
Year Ending Dec-17 151.41 84.53 18.07 18.07 8.53
Year Ending Dec-18 23.22 23.31 40.37 40.37 3.90

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 1 0
Quarter Ending Mar-18 0 0 0 1
Year Ending Dec-17 0 0 1 0
Year Ending Dec-18 0 0 0 1
Earnings